{{chembox
| reference = <ref>''Merck Index'', 11th Edition, '''9968'''.</ref>
| ImageFile = Xanthin - Xanthine.svg
| ImageSize = 200px
| IUPACName = 3,7-Dihydro-purine-2,6-dione
| OtherNames = 1''H''-Purine-2,6-diol
| Section1 = {{Chembox Identifiers
| CASNo = 69-89-6
| CASNo_Ref = {{cascite|correct|CAS}}
|  Abbreviations  =  
|  EINECS  =  
|  PubChem  =  1188
|  SMILES  =  O=C1NC(=O)c2[nH]cnc2N1
|  InChI  =  
|  RTECS  = 
|  MeSHName  = 
|  ChEBI  = 
|  KEGG  =  
|  ATCCode_prefix  =  
|  ATCCode_suffix  =  
|  ATC_Supplemental  = |  IUPHAR_ligand  =  4557
|  InChIKey1  =  LRFVTYWOQMYALW-UHFFFAOYSA-N
|  InChI1  =  1S/C5H4N4O2/c10-4-2-3(7-1-6-2)8-5(11)9-4/h1H,(H3,6,7,8,9,10,11)
|  ChemSpiderID_Ref  = {{chemspidercite|correct|chemspider}}|  ChemSpiderID  =  1151
|  DrugBank_Ref  = {{drugbankcite|changed|drugbank}}|  DrugBank  =  DB02134
|  UNII_Ref  = {{fdacite|changed|FDA}}|  UNII  =  1AVZ07U9S7
|  StdInChIKey_Ref  = {{stdinchicite|changed|chemspider}}|  StdInChIKey  =  LRFVTYWOQMYALW-UHFFFAOYSA-N
|  ChEMBL_Ref  = {{ebicite|correct|EBI}}|  ChEMBL  =  1424
|  StdInChI_Ref  = {{stdinchicite|correct|chemspider}}|  StdInChI  =  1S/C5H4N4O2/c10-4-2-3(7-1-6-2)8-5(11)9-4/h1H,(H3,6,7,8,9,10,11)
|  ChEBI_Ref  = {{ebicite|changed|EBI}}|  KEGG_Ref  = {{keggcite|changed|kegg}}
}}
| Section2 = {{Chembox Properties
| Formula = C<sub>5</sub>H<sub>4</sub>N<sub>4</sub>O<sub>2</sub>
| MolarMass = 152.111
| Appearance = 白色固体
| Density = 
| MeltingPt = （加热分解）
| Melting_notes =
| BoilingPt = 
| Boiling_notes = 
| Solubility = 1 g/ 14.5 L @ 16 °C<br>1 g/1.4 L @ 100 °C
| SolubleOther = 
| Solvent = 
| pKa = 
| pKb = }}
| Section7 = {{Chembox Hazards
| EUClass = 
| EUIndex = 
| MainHazards = 
| NFPA-H = 
| NFPA-F = 
| NFPA-R = 
| NFPA-O =
| RPhrases = 
| SPhrases = 
| RSPhrases =
| FlashPt = 
| Autoignition = 
| ExploLimits = 
| PEL = }}
}}

'''黄嘌呤'''（{{lang-en|'''xanthine'''}}）是一種廣泛分佈於人體及其他生物體的器官及體液中的一種[[嘌呤|嘌呤]][[鹼|鹼]]，常用作温和的兴奋剂和支气管扩张剂，特别用于治疗[[哮喘|哮喘]]症状。[[咖啡因|咖啡因]]、[[茶碱|茶碱]]及[[可可碱|可可碱]]（主要在[[巧克力|巧克力]]中发现）等常見的溫和[[興奮劑|興奮劑]]均由黄嘌呤衍生出來。<ref>Spiller, Gene A. (1998). Caffeine. Boca Raton: CRC Press. ISBN 0-8493-2647-8 .</ref> <ref>{{cite journal | last=Daly | first=J. W. | last2=Padgett | first2=W. L. | last3=Shamim | first3=M. T. | title=Analogs of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors | journal=Journal of Medicinal Chemistry | publisher=American Chemical Society (ACS) | volume=29 | issue=7 | year=1986 | issn=0022-2623 | doi=10.1021/jm00157a035 | pages=1305–1308}}. PMID 3806581</ref> <ref>{{cite journal | last=Choi | first=Oksoon H. | last2=Shamim | first2=Mah T. | last3=Padgett | first3=William L. | last4=Daly | first4=John W. | title=Caffeine and theophylline analogues: Correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors | journal=Life Sciences | publisher=Elsevier BV | volume=43 | issue=5 | year=1988 | issn=0024-3205 | doi=10.1016/0024-3205(88)90517-6 | pages=387–398}}. PMID 2456442</ref><ref name="PTX-Deree">{{cite journal | author=Deree J, Martins JO, Melbostad H, Loomis WH, Coimbra R. | title=Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition | journal=Clinics (São Paulo). | year=2008 | pages=321–8 | volume=63 | issue=3 | pmid=18568240 | doi=10.1590/S1807-59322008000300006 | pmc=2664230 }}</ref>

黄嘌呤也是[[嘌呤代謝|嘌呤代謝]]後的产物，并会在[[黄嘌呤氧化酶|黄嘌呤氧化酶]]的作用下转换为[[尿酸|尿酸]]，有時累積過度會在某些人群中造成[[痛風|痛風]]的症狀。

黄嘌呤是[[嘌呤|嘌呤]]衍生物，并且很少在[[核酸|核酸]]的成分中发现。

==參見==
*[[次黄嘌呤|次黄嘌呤]]（6-羥基嘌呤）
*{{link-en|副黄嘌呤|Paraxanthine}}（1,7-二甲基黄嘌呤）

== 參考文獻 ==
{{reflist}}

{{鹼基、核苷和核苷酸}}
{{Nucleotide metabolism intermediates}}

[[Category:黄嘌呤类|]]